Accettella Christopher

BlackRock executive Accettella buys 1,190 shares of BMEZ at $15.17; holdings rise to 4,069 shares (+41.3%)

Christopher Accettella purchased 1,190 shares of BlackRock Health Sciences Term Trust at $15.17 on January 11, 2024, increasing his holdings by 41.3% to 4,069 shares. The transaction occurred near the midpoint of the 52-week range ($13.02–$16.54) and modestly below the current price of $15.89. This is a routine buy transaction by an insider in a closed-end fund; the scale and holding-size increase suggest a discretionary purchase, though without flagging information, the timing context and strategic reasoning are not discernible from this filing alone.